IL6 and congenital rubella syndrome: In total, 8.3% severe CRS reaction was observed, and no neurotoxicity was found, and only 2 patients had significantly high plasma levels of IL-6 and ferritin after CAR-T treatment, which was consistent with the previous CD30 CAR-T studies of low toxicity characteristics (12, 13).